Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Xeris Biopharma COO Sells 15,000 Shares Under 10b5-1 Plan

Kevin McCulloch, President and Chief Operating Officer of Xeris Biopharma Holdings, Inc., filed a Form 4 on September 1, 2026, disclosing the sale of 15,000 shares of common stock pursuant to a previously adopted Rule 10b5-1 trading plan.

Nitish Kishor | 01 September 2026

Five9 President Andy Dignan Sells 17,767 Shares

A Form 4 filed with the SEC on September 1, 2026, discloses that Andy Dignan, President of Five9, Inc. (NASDAQ:FIVN), sold 17,767 shares of common stock on August 28, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.

Nitish Kishor | 01 September 2026

Guidewire Software CEO Sells 1,200 Shares Under 10b5-1 Plan

A Form 4 filed with the SEC on September 1, 2026, discloses that Michael George Rosenbaum, Chief Executive Officer and Director of Guidewire Software, Inc. (NYSE:GWRE), sold 1,200 shares of common stock on August 31, 2026, pursuant to a pre-established 10b5-1 trading plan.

Manish Choudhary | 01 September 2026

Microsoft CEO Satya Nadella Reports Stock Vesting and Tax Withholding

A Form 4 filed on September 1, 2026, discloses that Satya Nadella, Chief Executive Officer and Director of Microsoft Corp (NASDAQ:MSFT), acquired 178,622 shares of common stock through a performance stock award vesting on August 31, 2026, and had 70,465.844 shares withheld for taxes …

Shwetambri Chauhan | 01 September 2026

Microsoft CMO Takeshi Numoto Reports Stock Transactions

A Form 4 filed on September 1, 2026 with the SEC discloses that Takeshi Numoto, Executive Vice President and Chief Marketing Officer of Microsoft Corp (NASDAQ:MSFT), reported the vesting of a performance stock award and a related tax withholding disposition of common stock on …

Manish Choudhary | 01 September 2026

Microsoft President Bradford Smith Reports Stock Transactions

Bradford L. Smith, Vice Chair and President of Microsoft Corp (NASDAQ:MSFT), filed a Form 4 on September 1, 2026, disclosing transactions in Microsoft common stock dated August 31, 2026.

Vinay Lochav | 01 September 2026

Castle Biosciences CEO Files Form 4 on Stock Sales and Option Exercise

Derek J. Maetzold, President and Chief Executive Officer of Castle Biosciences Inc., filed a Form 4 on September 1, 2026, disclosing stock option exercises and common stock sales executed on August 28, 2026, under a pre-established Rule 10b5-1 trading plan.

Aakashdeep | 01 September 2026

Kulicke & Soffa CEO Receives 89,697 Share Grant

Rajendra K Talluri, CEO and Director of Kulicke & Soffa Industries Inc, filed a Form 4 on September 1, 2026, reporting the acquisition of 89,697 shares of common stock at no cost under the company's 2021 Omnibus Incentive Plan.

Shwetambri Chauhan | 01 September 2026

Avery Dennison President Receives Equity Awards

Danny Gilad Allouche, President of the Materials Group at Avery Dennison Corp (NYSE:AVY), filed a Form 4 on September 1, 2026, reporting the acquisition of three equity awards granted on September 1, 2026.

Aakashdeep | 01 September 2026

Avery Dennison Director Receives RSU Grant as Board Chair

A Form 4 filed on September 1, 2026, discloses that William Raymond Wagner, a director of Avery Dennison Corp (NYSE:AVY), received a supplemental restricted stock unit award in connection with his election as independent Board Chair.

Shwetambri Chauhan | 01 September 2026
Support

Hi! How can we help you today?

Loading…